These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Wolfe F; Marmor MF Arthritis Care Res (Hoboken); 2010 Jun; 62(6):775-84. PubMed ID: 20535788 [TBL] [Abstract][Full Text] [Related]
29. Electrophysiologic findings in chloroquine maculopathy. Halfeld Furtado de Mendonça R; Maia OO; Yukihiko Takahashi W Doc Ophthalmol; 2007 Sep; 115(2):117-9. PubMed ID: 17562091 [TBL] [Abstract][Full Text] [Related]
30. [Atypical hydroxychloroquine maculopathy in an Asian woman with lupus]. Messiant V; Defoort-Dhellemmes S; Smirnov V J Fr Ophtalmol; 2019 Dec; 42(10):1134-1136. PubMed ID: 31285064 [No Abstract] [Full Text] [Related]
31. Hydroxychloroquine Causes Early Inner Retinal Toxicity and Affects Autophagosome-Lysosomal Pathway and Sphingolipid Metabolism in the Retina. Mondal K; Porter H; Cole J; Pandya HK; Basu SK; Khanam S; Chiu CY; Shah V; Stephenson DJ; Chalfant CE; Mandal N Mol Neurobiol; 2022 Jun; 59(6):3873-3887. PubMed ID: 35426574 [TBL] [Abstract][Full Text] [Related]
32. Stevens-Johnson syndrome in association with hydroxychloroquine treatment for rheumatoid arthritis. Leckie MJ; Rees RG Rheumatology (Oxford); 2002 Apr; 41(4):473-4. PubMed ID: 11961185 [No Abstract] [Full Text] [Related]
33. Hydroxychloroquine-induced hyperpigmentation. Cho EB; Kim BC; Park EJ; Kwon IH; Cho HJ; Kim KH; Kim KJ J Dermatol; 2012 Oct; 39(10):859-60. PubMed ID: 22671572 [No Abstract] [Full Text] [Related]
34. Retinal toxicity associated with hydroxychloroquine and chloroquine: risk factors, screening, and progression despite cessation of therapy. Michaelides M; Stover NB; Francis PJ; Weleber RG Arch Ophthalmol; 2011 Jan; 129(1):30-9. PubMed ID: 21220626 [TBL] [Abstract][Full Text] [Related]
35. Hypoglycemia induced by hydroxychloroquine in a patient treated for rheumatoid arthritis. Unübol M; Ayhan M; Guney E J Clin Rheumatol; 2011 Jan; 17(1):46-7. PubMed ID: 21169846 [No Abstract] [Full Text] [Related]
36. Implanted pacemaker failure caused by the antirheumatic drug hydroxychloroquine. Huang PH; Tuan TC; Lin YJ; Ding YA; Kong CW Lupus; 2003; 12(9):725-7. PubMed ID: 14514140 [No Abstract] [Full Text] [Related]
37. [Chloroquine and hydroxychloroquine maculopathy: a review of diagnostic and therapeutic guidelines in Hungarian and international clinical practice]. Fodor M; Lukács MÁ; Szekanecz Z; Nagy ZZ Orv Hetil; 2024 Jul; 165(30):1147-1153. PubMed ID: 39068644 [TBL] [Abstract][Full Text] [Related]
38. Progression of hydroxychloroquine toxic effects after drug therapy cessation: new evidence from multimodal imaging. Mititelu M; Wong BJ; Brenner M; Bryar PJ; Jampol LM; Fawzi AA JAMA Ophthalmol; 2013 Sep; 131(9):1187-97. PubMed ID: 23887202 [TBL] [Abstract][Full Text] [Related]